Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TAVR: Pre-Existing Complete Right Bundle Branch Block Is Associated with Mortality

Courtesy of Dr. Carlos Fava.

TAVR: Pre-Existing Complete Right Bundle Branch Block

The fact that the presence of a complete right bundle branch block (RBBB) increases the risk of bradycardia, high-grade atrioventricular block, and need for a permanent pacemaker (PPM) after TAVR is well-known.

 

The impact of pre-existing complete right bundle branch block has not been well-studied. 

 

This article analyses 749 patients enrolled in the OCEAN TAVI study, 102 (13.6%) of which presented pre-existing complete right bundle branch block. All patients received an Edwards SAPIENS XT valve.

 

No differences were observed among groups, except for a higher prevalence of cerebrovascular disease in patients in the pre-existing complete right bundle branch block group (21.6% vs. 13%; p = 0.02), who also presented a higher annular area.

 

After implantation, this group presented higher life-threatening bleeding (11.8 vs. 6%; p = 0.03) and a higher need for a pacemaker (17.6% vs. 2.9%).

 

Patients in the complete right bundle branch block group showed a trend toward lower survival rates at 30 days (96% vs. 98.6%; p = 0.09).

 

At the 492-day follow-up (325-660), the incidence of aortic regurgitation and ventricular function was similar among groups. The rates of all-cause death, cardiac death, and death from heart failure was higher for patients with complete right bundle branch block.

 

In the Kaplan-Meier analysis, the presence of complete right bundle branch block without pacemaker was associated with a higher rate of early cardiac death, and follow-up revealed higher mortality rates in patients with complete right bundle branch block and pacemaker.

 

In a multivariate analysis, pre-existing complete right bundle branch block was an independent predictor of mortality.

 

Conclusion

Patients with complete right bundle branch block showed an increase in the risk of cardiovascular mortality after TAVR, and patients with complete right bundle branch block without pacemaker presented a higher risk of early cardiac death. Patients with prior complete right bundle branch block should be carefully monitored after TAVR.

 

Editorial

The presence of complete right bundle branch block surely reflects high-risk conditions that have not been well studied yet.

 

We should carry out a thorough monitoring of this high-risk patient group and anticipate both the need for a pacemaker after discharge and the presence of heart failure. That way, we may be able to lower mortality rates.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Original title: Pre-Existing Right Bundle Branch Block Increases Risk for Death After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve.

Reference: Yusuke Watanabe et al, J Am Coll Cardiol Intv 2016;9:2210-6.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...